Study Overview: This research is testing a new drug called AR1005 to see if it can help people with Lewy body disease, a condition that affects memory and thinking. The study will include 60 people, all over 60 years old, who have memory problems due to this disease.
Procedure: Participants will be randomly assigned to receive either AR1005 or a placebo, which is a harmless pill. All participants will continue their usual treatment with a drug called rivastigmine for 20 weeks. The researchers will check if AR1005 helps improve memory, behavior, and movement.
Eligibility: To join, participants must understand and agree to the study, have certain memory test scores, and show specific signs of Lewy body disease. They also need to have a caregiver and be able to walk or move with help. People with certain other health conditions, allergies to the study drug, or those already on similar medications cannot participate.
- The study lasts for 20 weeks.
- Participants will need to take medication and attend appointments.
- Risks include potential side effects of the study drug.
How understandable was the trial content above?
Hard to understand
Easy to understand